Apex Healthcare Bhd (7090) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Apex Healthcare Bhd (7090) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM29.41 Million ≈ $7.38 Million USD) by net assets (RM779.26 Million ≈ $195.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Apex Healthcare Bhd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Apex Healthcare Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Apex Healthcare Bhd for a breakdown of total debt and financial obligations.
Apex Healthcare Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apex Healthcare Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elite Color Environmental Resources
SHE:002998
|
0.002x |
|
VST Industries Limited
NSE:VSTIND
|
0.055x |
|
Chaince Digital Holdings Inc.
NASDAQ:CD
|
-0.025x |
|
Tieling Newcity Investment Holding Ltd
SHE:000809
|
-0.022x |
|
Diamond Hill Investment Group Inc
NASDAQ:DHIL
|
0.095x |
|
First Business Financial Services
NASDAQ:FBIZ
|
0.008x |
|
Titan International Inc
NYSE:TWI
|
-0.093x |
|
B+S GROUP SA INH EO-06
F:70B
|
N/A |
Annual Cash Flow Conversion Efficiency for Apex Healthcare Bhd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Apex Healthcare Bhd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Apex Healthcare Bhd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | RM789.62 Million ≈ $198.25 Million |
RM69.00 Million ≈ $17.32 Million |
0.087x | +23.08% |
| 2023-12-31 | RM918.27 Million ≈ $230.55 Million |
RM65.19 Million ≈ $16.37 Million |
0.071x | -44.99% |
| 2022-12-31 | RM558.43 Million ≈ $140.20 Million |
RM72.07 Million ≈ $18.09 Million |
0.129x | +5.82% |
| 2021-12-31 | RM506.86 Million ≈ $127.26 Million |
RM61.82 Million ≈ $15.52 Million |
0.122x | -33.24% |
| 2020-12-31 | RM467.97 Million ≈ $117.49 Million |
RM85.49 Million ≈ $21.46 Million |
0.183x | +13.81% |
| 2019-12-31 | RM425.53 Million ≈ $106.84 Million |
RM68.30 Million ≈ $17.15 Million |
0.161x | +53.12% |
| 2018-12-31 | RM385.99 Million ≈ $96.91 Million |
RM40.46 Million ≈ $10.16 Million |
0.105x | -22.33% |
| 2017-12-31 | RM343.23 Million ≈ $86.17 Million |
RM46.32 Million ≈ $11.63 Million |
0.135x | +24.58% |
| 2016-12-31 | RM311.97 Million ≈ $78.33 Million |
RM33.80 Million ≈ $8.49 Million |
0.108x | +35.65% |
| 2015-12-31 | RM288.00 Million ≈ $72.31 Million |
RM23.00 Million ≈ $5.77 Million |
0.080x | -40.67% |
| 2014-12-31 | RM260.00 Million ≈ $65.28 Million |
RM35.00 Million ≈ $8.79 Million |
0.135x | +17.17% |
| 2013-12-31 | RM235.00 Million ≈ $59.00 Million |
RM27.00 Million ≈ $6.78 Million |
0.115x | -19.95% |
| 2012-12-31 | RM216.00 Million ≈ $54.23 Million |
RM31.00 Million ≈ $7.78 Million |
0.144x | -- |
About Apex Healthcare Bhd
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more